Loading…
Will TAVR Become the Default Treatment for Patients With Severe Aortic Stenosis?
[...]of these studies, the U.S. Food and Drug Administration granted approval for the marketing of TAVR, and it has become the standard of care in patients who are at extreme risk for surgery. [...]the mechanism for superiority of TAVR over SAVR in this analysis remains uncertain. Because approximat...
Saved in:
Published in: | Journal of the American College of Cardiology 2015-07, Vol.66 (2), p.122-124 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [...]of these studies, the U.S. Food and Drug Administration granted approval for the marketing of TAVR, and it has become the standard of care in patients who are at extreme risk for surgery. [...]the mechanism for superiority of TAVR over SAVR in this analysis remains uncertain. Because approximately 17% of the cases in the TAVR arm were performed via a noniliofemoral approach (8), the statements of superiority should be carefully reviewed for the TAVR alternative access. |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/j.jacc.2015.05.016 |